Department of Thoracic Surgery and Thoracic Oncology, Virginia Mason Medical Center, Seattle, WA.
Department of Surgery and Cancer, Imperial College London, UK.
Ann Surg. 2022 Jan 1;275(1):e140-e147. doi: 10.1097/SLA.0000000000003829.
The aim of this study was to investigate long-term HRQOL and symptom evolution in disease free patients up to 20 years after esophagectomy.
Esophagectomy has been associated with decreased HRQOL and persistent gastrointestinal symptoms.
The study cohort was identified from 2 high volume centers for the management of esophageal cancer. Patients completed HRQOL and symptom questionnaires, including: Digestive Symptom Questionnaire, EORTC QLQ-C30, EORTC QLQ-OG25 Euro QoL 5D, and SF36. Patients were assessed in 3 cohorts: <1 year; 1-5 years, and; >5 years after surgery.
In total 171 of 222 patients who underwent esophagectomy between 1991 and 2017 who met inclusion criteria and were contactable, responded to the questionnaires, corresponding to a response rate of 77%. Median age was 66.2 years, and median time from operation to survey was 5.6 years (range 0.3-23.1). Early satiety was the most commonly reported symptom in all patients irrespective of timeframe (87.4%; range 82%-92%). Dysphagia was seen to decrease over time (58% at <2 years; 28% at 2-5 years; 20% at >5 years; P = 0.013). Weight loss scores demonstrated nonstatistical improvement over time. All other symptom scores including heartburn, regurgitation, respiratory symptoms, and pain scores remained constant over time. Average HRQOL did not improve from levels 1 year after surgery compared to patients up to 23 years after esophagectomy.
With the exception of dysphagia, which improved over time, esophagectomy was associated with decreased HRQOL and lasting gastrointestinal symptoms up to 20 years after surgery. Pertinently however long-term survivors after oesophagectomy demonstrated comparable to improved HRQOL compared to the general population. The impact of esophagectomy on gastrointestinal symptoms and long-term HRQOL should be considered when counseling and caring for patients undergoing esophagectomy.
本研究旨在调查无疾病患者在食管癌手术后 20 年内的 HRQOL 和症状演变。
食管癌与 HRQOL 下降和持续的胃肠道症状有关。
研究队列是从 2 个管理食管癌的高容量中心中确定的。患者完成了 HRQOL 和症状问卷,包括:消化症状问卷、EORTC QLQ-C30、EORTC QLQ-OG25 Euro QoL 5D 和 SF36。患者分为 3 个队列进行评估:手术后<1 年;1-5 年;>5 年。
在 1991 年至 2017 年间接受食管癌手术且符合纳入标准并可联系的 222 名患者中,共有 171 名患者对问卷做出了回应,应答率为 77%。中位年龄为 66.2 岁,从手术到调查的中位时间为 5.6 年(范围 0.3-23.1)。早饱是所有患者无论时间框架如何最常见的症状(87.4%;范围 82%-92%)。随着时间的推移,吞咽困难逐渐减轻(<2 年为 58%;2-5 年为 28%;>5 年为 20%;P=0.013)。体重减轻评分随时间呈非统计学改善。其他所有症状评分,包括烧心、反流、呼吸症状和疼痛评分,随时间保持不变。与手术后 1 年相比,手术后 23 年的患者 HRQOL 没有改善。
除了吞咽困难随着时间的推移而改善外,食管癌与 HRQOL 下降和持续的胃肠道症状有关,在手术后 20 年内仍然存在。然而,长期生存的食管癌患者的 HRQOL 与一般人群相当或有所改善。在为接受食管癌手术的患者提供咨询和护理时,应考虑食管癌对胃肠道症状和长期 HRQOL 的影响。